CA2449490A1 - System and method for milling materials - Google Patents
System and method for milling materials Download PDFInfo
- Publication number
- CA2449490A1 CA2449490A1 CA002449490A CA2449490A CA2449490A1 CA 2449490 A1 CA2449490 A1 CA 2449490A1 CA 002449490 A CA002449490 A CA 002449490A CA 2449490 A CA2449490 A CA 2449490A CA 2449490 A1 CA2449490 A1 CA 2449490A1
- Authority
- CA
- Canada
- Prior art keywords
- milling
- chamber
- head
- drive
- milling chamber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
- B02C17/18—Details
- B02C17/24—Driving mechanisms
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B02—CRUSHING, PULVERISING, OR DISINTEGRATING; PREPARATORY TREATMENT OF GRAIN FOR MILLING
- B02C—CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN
- B02C17/00—Disintegrating by tumbling mills, i.e. mills having a container charged with the material to be disintegrated with or without special disintegrating members such as pebbles or balls
- B02C17/16—Mills in which a fixed container houses stirring means tumbling the charge
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T409/00—Gear cutting, milling, or planing
- Y10T409/30—Milling
Abstract
A system for milling at least one material, e.g., a drug. The system include s a milling apparatus and at least one milling medium. The milling apparatus includes a chamber having a rotary milling head located in it. The milling head is rotated within the chamber by a magnetic drive system.
Claims (45)
1. A system for milling at least one material, said system comprising a milling apparatus and at least one milling medium for use therewith, said apparatus comprising a milling chamber, a milling head, and a drive member, said milling chamber comprising a hollow vessel for receipt of the at least one material and said at least one milling medium therein, said drive member including at least one drive magnet, said milling head being located within said milling chamber, being rotatably mounted with respect thereto and including at least one driven magnet, said at least one drive magnet being magnetically coupled to said at least one driven magnet, said drive member being arranged to be rotated by an energy source, whereupon rotation of said drive member effects the concomitant rotation of said milling head with respect to said milling chamber, said milling head cooperating with said at least one milling medium and with the at least one material to effect the milling of the at least one material within said milling chamber.
2. The system of Claim 1 wherein said milling chamber is removably mounted with respect to said drive member, whereupon said milling chamber and said milling head can be removed as a unit from said drive member.
3. The system of Claim 1 wherein said milling chamber includes a removable cover.
4. The system of Claim 2 wherein said milling chamber includes a removable cover.
5. The system of Claim 1 wherein said drive member is a shaft that is oriented vertically and is rotated by a motor.
6. The system of Claim 2 wherein said drive member is a shaft that is oriented vertically and is rotated by a motor.
7. The system of Claim 1 wherein said milling head includes at least one member projecting outward therefrom for cooperating with said milling medium and with the material to effect the milling of the at least one material within said milling chamber.
8. The system of Claim 7 wherein said milling head comprises a plurality of pegs projecting outward therefrom.
9. The system of Claim 1 additionally comprising at least one bearing rotatably mounting said milling head within said milling chamber.
10. The system of Claim 1 wherein said at least one drive magnet is a rare earth magnet.
11. The system of Claim 1 wherein said at least one driven magnet is a rare earth magnet.
12. The system of Claim 10 wherein said at least one driven magnet is a rare earth magnet.
13. The system of Claim 1 wherein said milling media comprise a plurality of small bodies.
14. The system of Claim 13 wherein said small bodies are approximately 500 microns in mean diameter or less.
15. The system of Claim 1 wherein said at least one milling media comprise polymeric material.
16. The system of Claim 13 wherein said at least one milling media comprise polymeric material.
17. The system of Claim 14 wherein said at least one milling media comprise polymeric material.
18. The system of Claim 1 wherein said drive member comprises a drive shaft having a first end portion, a longitudinal axis and wherein said at least one drive magnet is coupled to said drive shaft at said first end portion, said milling head having a central bore in which a portion of said milling chamber is located but spaced slightly therefrom, said at least one driven magnet being located adjacent said central bore, said drive shaft being arranged to be rotated about said longitudinal axis by the energy source, whereupon rotation of said drive shaft about said longitudinal axis effects the concomitant rotation of said milling head about said longitudinal axis.
19. The system of Claim 18 wherein said portion of said milling chamber comprises a spindle having a central well therein.
20. The system of Claim 19 wherein said first end portion of said drive shaft is located within said central well and wherein said at least one drive magnet is magnetically coupled to said at least one driven magnet via said spindle.
21. The system of Claim 18 wherein said milling chamber is removably mounted with respect to said drive shaft, whereupon said milling chamber and said milling head can be removed as a unit from said drive shaft.
22. The system of Claim 18 wherein said milling chamber includes a removable cover.
23. The system of Claim 21 wherein said milling chamber includes a removable cover.
24. The system of Claim 22 wherein said drive shaft is oriented vertically and the energy source is a motor to which said drive shaft is coupled.
25. The system of Claim 18 wherein said milling head includes at least one member projecting outward therefrom for cooperating with said milling medium and with the material to effect the milling of the at least one material within said milling chamber.
26. The system of Claim 25 wherein said milling head comprises a plurality of pegs projecting outward therefrom.
27. The system of Claim 20 wherein said milling head includes at least one member projecting outward therefrom for cooperating with said milling medium and with the material to effect the milling of the at least one material within said milling chamber.
28. The system of Claim 27 wherein said milling head comprises a plurality of pegs projecting outward therefrom.
29. The system of Claim 18 additionally comprising at least one bearing rotatably mounting said milling head on said portion of said milling chamber.
30. The system of Claim 19 additionally comprising at least one bearing rotatably mounting said milling head on said spindle.
31. The system of Claim 20 wherein said at least one drive magnet is a rare earth magnet.
32. The system of Claim 20 wherein said milling media comprise a plurality of small bodies.
33. The system of Claim 32 wherein said small bodies are approximately 500 microns in mean diameter or less.
34. The system of Claim 20 wherein said at least one milling media comprise polymeric material.
35. The system of Claim 33 wherein said at least one milling media comprise polymeric material.
36. The system of Claim 1 wherein the material is a drug.
37. The system of Claim 1 wherein the material is a diagnostic imaging agent.
38. A method for milling at least one material comprising:
(A) providing a milling chamber having a milling head located therein;~
(B) providing the at least one material in said milling chamber;
(C) providing at least one milling medium in said milling chamber;
(D) providing a shaft arranged to be rotated about a longitudinal axis by a source of energy; and (E) Magnetically coupling said shaft to said milling head to rotate said milling head about said axis in said milling chamber, whereupon rotation of said shaft about said axis effects the concomitant rotation of said milling head to effect the milling of the at least one material within said milling chamber.
(A) providing a milling chamber having a milling head located therein;~
(B) providing the at least one material in said milling chamber;
(C) providing at least one milling medium in said milling chamber;
(D) providing a shaft arranged to be rotated about a longitudinal axis by a source of energy; and (E) Magnetically coupling said shaft to said milling head to rotate said milling head about said axis in said milling chamber, whereupon rotation of said shaft about said axis effects the concomitant rotation of said milling head to effect the milling of the at least one material within said milling chamber.
39. The method of Claim 38 wherein said milling chamber is releasably mounted on said shaft, and wherein said method comprises removing said milling chamber and said milling head as a unit from said shaft.
40. The method of Claim 38 wherein said at least one milling medium comprises a plurality of small bodies.
41. The method of Claim 40 wherein said plurality of small bodies are approximately 500 microns in mean diameter or less.
42. The method of Claim 40 wherein said plurality of small bodies are formed of a polymeric material.
43. The method of Claim 41 wherein said plurality of small bodies are formed of a polymeric material.
44. The method of Claim 38 wherein the material is a drug.
45. The method of Claim 38 wherein the material is a diagnostic imaging agent.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29596501P | 2001-06-05 | 2001-06-05 | |
US60/295,965 | 2001-06-05 | ||
PCT/US2002/017323 WO2002098565A1 (en) | 2001-06-05 | 2002-05-31 | System and method for milling materials |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2449490A1 true CA2449490A1 (en) | 2002-12-12 |
CA2449490C CA2449490C (en) | 2010-10-05 |
Family
ID=23139990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2449490A Expired - Lifetime CA2449490C (en) | 2001-06-05 | 2002-05-31 | System and method for milling materials |
Country Status (12)
Country | Link |
---|---|
US (3) | US6742734B2 (en) |
EP (1) | EP1392441B1 (en) |
JP (1) | JP4223390B2 (en) |
AT (1) | ATE401959T1 (en) |
AU (1) | AU2002312230A1 (en) |
CA (1) | CA2449490C (en) |
CY (1) | CY1108429T1 (en) |
DE (1) | DE60227802D1 (en) |
DK (1) | DK1392441T3 (en) |
ES (1) | ES2309177T3 (en) |
PT (1) | PT1392441E (en) |
WO (1) | WO2002098565A1 (en) |
Families Citing this family (81)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080102121A1 (en) * | 1998-11-02 | 2008-05-01 | Elan Pharma International Limited | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone |
US6428814B1 (en) | 1999-10-08 | 2002-08-06 | Elan Pharma International Ltd. | Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
US7198795B2 (en) | 2000-09-21 | 2007-04-03 | Elan Pharma International Ltd. | In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions |
US7998507B2 (en) | 2000-09-21 | 2011-08-16 | Elan Pharma International Ltd. | Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors |
US7276249B2 (en) | 2002-05-24 | 2007-10-02 | Elan Pharma International, Ltd. | Nanoparticulate fibrate formulations |
EP1339390A2 (en) * | 2000-12-06 | 2003-09-03 | Pharmacia Corporation | Laboratory scale milling process |
US6976647B2 (en) | 2001-06-05 | 2005-12-20 | Elan Pharma International, Limited | System and method for milling materials |
DE60227802D1 (en) * | 2001-06-05 | 2008-09-04 | Elan Pharma Int Ltd | GRINDING MACHINE AND METHOD FOR THE OPERATION |
US7758890B2 (en) | 2001-06-23 | 2010-07-20 | Lyotropic Therapeutics, Inc. | Treatment using dantrolene |
DE10141650C1 (en) | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Safe transdermal therapeutic system for administration of fentanyl or analogous analgesics, having matrix layer of carboxy group-free polyacrylate adhesive providing high permeation rate |
PT1471887E (en) | 2002-02-04 | 2010-07-16 | Elan Pharma Int Ltd | Nanoparticulate compositions having lysozyme as a surface stabilizer |
US9101540B2 (en) | 2002-04-12 | 2015-08-11 | Alkermes Pharma Ireland Limited | Nanoparticulate megestrol formulations |
US7101576B2 (en) | 2002-04-12 | 2006-09-05 | Elan Pharma International Limited | Nanoparticulate megestrol formulations |
JP4533134B2 (en) | 2002-06-10 | 2010-09-01 | エラン ファーマ インターナショナル,リミティド | Nanoparticulate policosanol formulations and novel policosanol combinations |
ES2355723T3 (en) | 2002-09-11 | 2011-03-30 | Elan Pharma International Limited | COMPOSITIONS OF ACTIVE AGENT IN GAN STABILIZED NANOPARTICLES. |
JP4469846B2 (en) | 2003-01-31 | 2010-06-02 | エラン ファーマ インターナショナル,リミティド | Nanoparticulate topiramate formulation |
US20100297252A1 (en) | 2003-03-03 | 2010-11-25 | Elan Pharma International Ltd. | Nanoparticulate meloxicam formulations |
US8512727B2 (en) | 2003-03-03 | 2013-08-20 | Alkermes Pharma Ireland Limited | Nanoparticulate meloxicam formulations |
US7140567B1 (en) * | 2003-03-11 | 2006-11-28 | Primet Precision Materials, Inc. | Multi-carbide material manufacture and use as grinding media |
JP2007501683A (en) | 2003-05-22 | 2007-02-01 | エラン ファーマ インターナショナル リミテッド | Sterilization of nanoparticle active substance dispersions by gamma irradiation |
CA2534924A1 (en) * | 2003-08-08 | 2005-02-24 | Elan Pharma International Ltd. | Novel metaxalone compositions |
US7879360B2 (en) | 2003-11-05 | 2011-02-01 | Elan Pharma International, Ltd. | Nanoparticulate compositions having a peptide as a surface stabilizer |
US7000850B2 (en) * | 2004-04-27 | 2006-02-21 | Brand New Technology Ltd. | Anti-scald water valve assembly |
US7910577B2 (en) | 2004-11-16 | 2011-03-22 | Elan Pharma International Limited | Injectable nanoparticulate olanzapine formulations |
UA89513C2 (en) * | 2004-12-03 | 2010-02-10 | Элан Фарма Интернешнл Лтд. | Nanoparticulate raloxifene hydrochloride composition |
CA2590675A1 (en) * | 2004-12-15 | 2006-06-22 | Elan Pharma International Ltd. | Nanoparticulate tacrolimus formulations |
US20060159767A1 (en) * | 2004-12-22 | 2006-07-20 | Elan Pharma International Limited | Nanoparticulate bicalutamide formulations |
CN101132770A (en) * | 2005-01-06 | 2008-02-27 | 伊兰制药国际有限公司 | Nanoparticulate candesartan formulations |
CA2597716A1 (en) * | 2005-02-15 | 2006-08-24 | Elan Pharma International Limited | Aerosol and injectable formulations of nanoparticulate benzodiazepine |
JP2008531721A (en) * | 2005-03-03 | 2008-08-14 | エラン・ファルマ・インターナショナル・リミテッド | Nanoparticulate compositions of heterocyclic amide derivatives |
US20060204588A1 (en) * | 2005-03-10 | 2006-09-14 | Elan Pharma International Limited | Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof |
KR20070118258A (en) * | 2005-03-16 | 2007-12-14 | 엘란 파마 인터내셔널 리미티드 | Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations |
MX2007011495A (en) * | 2005-03-17 | 2007-12-06 | Elan Pharma Int Ltd | Nanoparticulate biphosphonate compositions. |
EA200702049A1 (en) | 2005-03-23 | 2008-02-28 | Элан Фарма Интернэшнл Лтд. | COMPOSITIONS OF CORTICOSTEROID NANOPARTICLES WITH ANTIGISTAMINS |
MX2007012778A (en) * | 2005-04-12 | 2008-01-11 | Elan Pharma Int Ltd | Nanoparticulate quinazoline derivative formulations. |
US20110064803A1 (en) * | 2005-05-10 | 2011-03-17 | Elan Pharma International Limited. | Nanoparticulate and controlled release compositions comprising vitamin k2 |
BRPI0608771A2 (en) * | 2005-05-10 | 2010-01-26 | Elan Pharma Int Ltd | nanoparticulate clopidogrel formulations |
US20100028439A1 (en) * | 2005-05-23 | 2010-02-04 | Elan Pharma International Limited | Nanoparticulate stabilized anti-hypertensive compositions |
ES2341996T3 (en) * | 2005-06-03 | 2010-06-30 | Elan Pharma International Limited | IMATINIB MESILATE FORMULATIONS IN THE FORM OF MANOPARTICLES. |
CN101262860A (en) * | 2005-06-03 | 2008-09-10 | 伊兰制药国际有限公司 | Nanoparticulate acetaminophen formulations |
US20070042049A1 (en) * | 2005-06-03 | 2007-02-22 | Elan Pharma International, Limited | Nanoparticulate benidipine compositions |
CA2612994A1 (en) | 2005-06-08 | 2006-12-08 | Elan Pharma International Limited | Nanoparticulate and controlled release compositions comprising cefditoren |
US20070059371A1 (en) * | 2005-06-09 | 2007-03-15 | Elan Pharma International, Limited | Nanoparticulate ebastine formulations |
MX2007015882A (en) * | 2005-06-13 | 2008-03-04 | Elan Pharma Int Ltd | Nanoparticulate clopidogrel and aspirin combination formulations. |
WO2006138421A2 (en) * | 2005-06-15 | 2006-12-28 | Elan Pharma International Limited | Nanoparticulate azelnidipine formulations |
EP1904041A2 (en) * | 2005-07-07 | 2008-04-02 | Elan Pharma International Limited | Nanoparticulate clarithromycin formulations |
EP1937217A2 (en) * | 2005-09-13 | 2008-07-02 | Elan Pharma International Limited | Nanoparticulate tadalafil formulations |
EP1933814A2 (en) | 2005-09-15 | 2008-06-25 | Elan Pharma International Limited | Nanoparticulate aripiprazole formulations |
EP1984344B1 (en) | 2005-12-29 | 2012-09-26 | Lexicon Pharmaceuticals, Inc. | Multicyclic amino acid derivatives and methods of their use |
US7649098B2 (en) | 2006-02-24 | 2010-01-19 | Lexicon Pharmaceuticals, Inc. | Imidazole-based compounds, compositions comprising them and methods of their use |
US8367112B2 (en) * | 2006-02-28 | 2013-02-05 | Alkermes Pharma Ireland Limited | Nanoparticulate carverdilol formulations |
NZ545960A (en) * | 2006-03-15 | 2008-04-30 | Environmental Decontamination | Milling apparatus |
JP2009538927A (en) * | 2006-05-30 | 2009-11-12 | エラン ファーマ インターナショナル,リミティド | Nanoparticulate posaconazole formulation |
CA2657379A1 (en) * | 2006-07-10 | 2008-01-17 | Elan Pharma International Ltd. | Nanoparticulate sorafenib formulations |
KR20090031618A (en) * | 2006-07-12 | 2009-03-26 | 엘란 코포레이션, 피엘씨 | Nanoparticulate formulations of modafinil |
EP2124556B1 (en) | 2006-10-09 | 2014-09-03 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
UA99270C2 (en) | 2006-12-12 | 2012-08-10 | Лексикон Фармасьютикалз, Инк. | 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use |
US8889632B2 (en) | 2007-01-31 | 2014-11-18 | Dana-Farber Cancer Institute, Inc. | Stabilized p53 peptides and uses thereof |
CN101730708B (en) | 2007-03-28 | 2013-09-18 | 哈佛大学校长及研究员协会 | Stitched polypeptides |
EP2240022B1 (en) | 2008-01-09 | 2016-12-28 | Charleston Laboratories, Inc. | Bilayered tablets comprising oxycodone and promethazine |
US20090197780A1 (en) * | 2008-02-01 | 2009-08-06 | Weaver Jimmie D | Ultrafine Grinding of Soft Materials |
CA2715422A1 (en) * | 2008-03-21 | 2009-09-24 | Elan Pharma International Limited | Compositions for site-specific delivery of imatinib and methods of use |
CA2763456C (en) | 2009-05-27 | 2017-10-24 | Alkermes Pharma Ireland Limited | Reduction of flake-like aggregation in nanoparticulate active agent compositions |
EP2451274B1 (en) | 2009-07-08 | 2017-10-04 | Charleston Laboratories, Inc. | Pharmaceutical compositions |
CA2779681A1 (en) | 2009-11-05 | 2011-05-12 | Lexicon Pharmaceuticals, Inc. | Tryptophan hydroxylase inhibitors for the treatment of cancer |
US20130137635A1 (en) | 2010-02-10 | 2013-05-30 | Lexicon Pharmaceuticals, Inc. | Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease |
WO2011146583A2 (en) | 2010-05-19 | 2011-11-24 | Elan Pharma International Limited | Nanoparticulate cinacalcet formulations |
CA2807685C (en) | 2010-08-13 | 2020-10-06 | Aileron Therapeutics, Inc. | P53 derived peptidomimetic macrocycle |
US9096684B2 (en) | 2011-10-18 | 2015-08-04 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
JP6450192B2 (en) | 2012-02-15 | 2019-01-09 | エイルロン セラピューティクス,インコーポレイテッド | Triazole-bridged and thioether-bridged peptidomimetic macrocycles |
WO2013123266A1 (en) | 2012-02-15 | 2013-08-22 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
US20130303763A1 (en) | 2012-03-30 | 2013-11-14 | Michael D. Gershon | Methods and compositions for the treatment of necrotizing enterocolitis |
US9604919B2 (en) | 2012-11-01 | 2017-03-28 | Aileron Therapeutics, Inc. | Disubstituted amino acids and methods of preparation and use thereof |
WO2015071841A1 (en) | 2013-11-12 | 2015-05-21 | Druggability Technologies Holdings Limited | Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
JP2017521479A (en) | 2014-05-15 | 2017-08-03 | ラニ セラピューティクス, エルエルシー | Solid mass pharmaceutical composition comprising a polypeptide and / or protein and method for producing the same |
AU2015320549A1 (en) | 2014-09-24 | 2017-04-13 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
BR112017019738A2 (en) | 2015-03-20 | 2018-05-29 | Aileron Therapeutics Inc | peptidomimetic macrocycles and their uses |
CN105381843B (en) * | 2015-11-25 | 2017-08-15 | 河北新四达电机股份有限公司 | Low speed large torque moment permanent-magnet motor-direct-drive type Ball Mill System |
JP2019507181A (en) | 2016-03-04 | 2019-03-14 | チャールストン ラボラトリーズ,インコーポレイテッド | Pharmaceutical composition |
US10881135B1 (en) | 2017-11-10 | 2021-01-05 | Creative Destruction, LLC | Cyclonically cooled and filtered smoking water pipe and method |
CN109012906A (en) * | 2018-07-10 | 2018-12-18 | 黄玉发 | A kind of building waste compaction type crushing device |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2350534A (en) * | 1942-10-05 | 1944-06-06 | Rosinger Arthur | Magnetic stirrer |
GB947530A (en) * | 1961-09-26 | 1964-01-22 | Gen Electric Co Ltd | Improvements in or relating to grinding mills, pelletising mills and like apparatus |
US4401672A (en) * | 1981-10-13 | 1983-08-30 | Regents Of The University Of Minnesota | Non-addictive narcotic antitussive preparation |
DE3345680A1 (en) | 1983-12-16 | 1985-06-20 | Gebrüder Netzsch, Maschinenfabrik GmbH & Co, 8672 Selb | AGITATOR MILL |
US4645131A (en) * | 1984-12-24 | 1987-02-24 | Hailey Robert W | Powder milling method to produce fine powder sizes |
DE3765316D1 (en) * | 1986-06-20 | 1990-11-08 | Inoue Mfg | DISPERSING AND GRINDING APPARATUS. |
FR2608988B1 (en) | 1986-12-31 | 1991-01-11 | Centre Nat Rech Scient | PROCESS FOR THE PREPARATION OF COLLOIDAL DISPERSIBLE SYSTEMS OF A SUBSTANCE, IN THE FORM OF NANOPARTICLES |
JPH0658069B2 (en) * | 1987-04-03 | 1994-08-03 | 三菱電機株式会社 | Engine accessory drive |
JPH01171627A (en) * | 1987-12-28 | 1989-07-06 | Inoue Seisakusho:Kk | Mixing and dispersing treatment device |
US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
NZ248813A (en) | 1992-11-25 | 1995-06-27 | Eastman Kodak Co | Polymeric grinding media used in grinding pharmaceutical substances |
TW384224B (en) | 1994-05-25 | 2000-03-11 | Nano Sys Llc | Method of preparing submicron particles of a therapeutic or diagnostic agent |
DE19533369C2 (en) * | 1995-09-09 | 1998-06-10 | Hermann Getzmann | Dispersing device and method |
DE19613366A1 (en) * | 1996-04-03 | 1997-10-09 | Goldschmidt Ag Th | Device for treating suspensions |
US6245357B1 (en) * | 1998-03-06 | 2001-06-12 | Alza Corporation | Extended release dosage form |
US6336603B1 (en) * | 1999-01-12 | 2002-01-08 | Island Oasis Frozen Cocktail Company, Inc. | Food processing apparatus including magnetic drive |
DE60227802D1 (en) * | 2001-06-05 | 2008-09-04 | Elan Pharma Int Ltd | GRINDING MACHINE AND METHOD FOR THE OPERATION |
-
2002
- 2002-05-31 DE DE60227802T patent/DE60227802D1/en not_active Expired - Lifetime
- 2002-05-31 ES ES02739588T patent/ES2309177T3/en not_active Expired - Lifetime
- 2002-05-31 PT PT02739588T patent/PT1392441E/en unknown
- 2002-05-31 AT AT02739588T patent/ATE401959T1/en active
- 2002-05-31 WO PCT/US2002/017323 patent/WO2002098565A1/en active Application Filing
- 2002-05-31 CA CA2449490A patent/CA2449490C/en not_active Expired - Lifetime
- 2002-05-31 EP EP02739588A patent/EP1392441B1/en not_active Expired - Lifetime
- 2002-05-31 JP JP2003501597A patent/JP4223390B2/en not_active Expired - Lifetime
- 2002-05-31 DK DK02739588.8T patent/DK1392441T3/en active
- 2002-05-31 AU AU2002312230A patent/AU2002312230A1/en not_active Abandoned
- 2002-06-04 US US10/162,333 patent/US6742734B2/en not_active Expired - Lifetime
-
2004
- 2004-04-27 US US10/832,374 patent/US20040195413A1/en not_active Abandoned
-
2007
- 2007-08-03 US US11/833,645 patent/US7575184B2/en not_active Expired - Lifetime
-
2008
- 2008-10-21 CY CY20081101175T patent/CY1108429T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2002312230A1 (en) | 2002-12-16 |
EP1392441A1 (en) | 2004-03-03 |
DE60227802D1 (en) | 2008-09-04 |
US20040195413A1 (en) | 2004-10-07 |
DK1392441T3 (en) | 2010-01-25 |
CY1108429T1 (en) | 2014-04-09 |
JP4223390B2 (en) | 2009-02-12 |
JP2004535919A (en) | 2004-12-02 |
US7575184B2 (en) | 2009-08-18 |
EP1392441B1 (en) | 2008-07-23 |
ES2309177T3 (en) | 2008-12-16 |
US20080025807A1 (en) | 2008-01-31 |
PT1392441E (en) | 2008-09-30 |
US6742734B2 (en) | 2004-06-01 |
US20020179758A1 (en) | 2002-12-05 |
WO2002098565A1 (en) | 2002-12-12 |
ATE401959T1 (en) | 2008-08-15 |
CA2449490C (en) | 2010-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2449490A1 (en) | System and method for milling materials | |
JP2004535919A5 (en) | ||
EP0756917A4 (en) | Separation type grinding surface plate and grinding apparatus using same | |
EP1037363A3 (en) | Motor for rotating a disk-shaped information recording medium in a disk drive apparatus | |
EP1592007A3 (en) | Data erasure apparatus, data erasure method and method for writing servo patterns on recording disk | |
JPH10180611A (en) | Magnetic grinding method and device based on generation of plurality of alternating fields | |
EP0810719A4 (en) | Multi-degree-of-freedom motor | |
HK1070132A1 (en) | Laboratory apparatus for grinding loose materials | |
WO2004098828A3 (en) | Motorized precision spindle apparatus | |
CN210054530U (en) | Magnetic traction device and lotus seed clamping device applying same | |
JPS6315947A (en) | Portable polishing apparatus for dental instrument | |
DE20307913U1 (en) | Laboratory bench rotary vacuum concentrator comprises internal magnetic drive, for slow removal of solvent in test tube scale preparations | |
KR970072164A (en) | Plasma processing chamber with planetary magnet source assembly | |
EP1946923A3 (en) | Reciprocating cylinder of an inking or dampening system | |
EP0926275A3 (en) | Open-end spinning device for making S or Z twist yarns | |
GB2412014A (en) | Toothbrush driven by magnets | |
JPS5645752A (en) | Stirrer | |
CN1531877A (en) | Device for removing foreign matter from tobacco | |
JPS63221965A (en) | Method and device for polishing pipe material | |
DE3368878D1 (en) | Washing apparatus | |
CN217702921U (en) | Semiconductor processing grinding device | |
CN214439824U (en) | Grinding device for drug synthesis | |
CN212051324U (en) | Microbial cultivation device | |
CN220372940U (en) | Inner wall rust removing equipment for needle bearing machining | |
CN209973060U (en) | Rotary bottling of anatomical specimen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20220531 |